David T Rubin Selected Research

Ulcerative Colitis

10/2022	A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
10/2022	CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
6/2022	Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center.
4/2022	Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data from a Large Tertiary Center.
2/2022	Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.
1/2022	Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium.
1/2022	Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis.
1/2022	Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study.
1/2022	Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis.
1/2022	Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David T Rubin Research Topics

Disease

85	Ulcerative Colitis 10/2022 - 01/2005
70	Crohn Disease (Crohn's Disease) 11/2022 - 01/2005
69	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 01/2005
27	Inflammation (Inflammations) 01/2022 - 08/2005
26	Neoplasms (Cancer) 02/2022 - 06/2005
20	Colitis 01/2022 - 06/2005
12	Infections 11/2022 - 01/2005
12	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 06/2005
11	Pouchitis 01/2022 - 01/2005
7	COVID-19 01/2022 - 01/2020
7	Necrosis 01/2022 - 04/2017
6	Rheumatoid Arthritis 06/2022 - 08/2017
6	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2022 - 08/2017
6	Fistula 04/2022 - 01/2005
5	Abdominal Pain (Pain, Abdominal) 10/2022 - 12/2008
5	Psoriatic Arthritis 05/2022 - 08/2017
5	Clostridium Infections 01/2022 - 12/2012
4	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2022 - 02/2008
4	Hemorrhage 01/2022 - 10/2014
3	Proctitis 11/2022 - 11/2015
3	Pathologic Constriction (Stenosis) 05/2021 - 05/2008
3	Arthritis (Polyarthritis) 01/2021 - 01/2019
3	Dysbiosis 11/2019 - 10/2013
3	Ankylosing Spondylitis 07/2019 - 08/2017
3	Carcinogenesis 01/2019 - 04/2007
3	Diarrhea 11/2015 - 01/2011
2	Wounds and Injuries (Trauma) 11/2022 - 01/2017
2	Venous Thromboembolism 01/2022 - 01/2021
2	Chronic Disease (Chronic Diseases) 12/2020 - 12/2008
2	Hypersensitivity (Allergy) 08/2020 - 09/2009
2	Human Influenza (Influenza) 01/2020 - 10/2016
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 10/2010
2	Proctocolitis (Hemorrhagic Proctocolitis) 01/2016 - 11/2015
2	Rectal Neoplasms (Rectal Cancer) 07/2009 - 08/2005

Drug/Important Bio-Agent (IBA)

20	vedolizumabIBA 10/2022 - 07/2015
18	SteroidsIBA 10/2022 - 01/2013
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 09/2009
14	tofacitinibIBA 01/2022 - 01/2018
12	Pharmaceutical PreparationsIBA 11/2022 - 05/2013
12	Adalimumab (Humira)FDA Link 01/2022 - 12/2008
12	Mesalamine (Mesalazine)FDA LinkGeneric 01/2021 - 06/2005
11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 09/2011
11	Biological ProductsIBA 10/2021 - 12/2008
10	Infliximab (Remicade)FDA Link 11/2020 - 08/2006
8	IntegrinsIBA 04/2022 - 07/2015
8	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 03/2013
7	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2022 - 01/2014
7	Ustekinumab (CNTO 1275)FDA Link 03/2022 - 12/2019
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2005
6	C-Reactive ProteinIBA 10/2022 - 05/2012
6	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022 - 05/2018
6	Capsules (Microcapsules)IBA 01/2020 - 05/2008
5	CytokinesIBA 05/2022 - 11/2013
5	InterleukinsIBA 05/2022 - 11/2013
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2009
4	Janus Kinase InhibitorsIBA 01/2022 - 01/2018
4	Monoclonal AntibodiesIBA 08/2020 - 09/2009
4	MicroRNAs (MicroRNA)IBA 04/2018 - 01/2012
4	Budesonide (Pulmicort)FDA LinkGeneric 12/2017 - 11/2015
4	AntibodiesIBA 01/2017 - 07/2015
3	Interleukin-23 (Interleukin 23)IBA 05/2022 - 08/2020
3	risankizumabIBA 01/2022 - 01/2020
3	Calcineurin InhibitorsIBA 10/2021 - 01/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2005
3	Biosimilar PharmaceuticalsIBA 11/2020 - 12/2016
3	Janus KinasesIBA 01/2019 - 01/2018
3	Immunologic Factors (Immunomodulators)IBA 01/2018 - 07/2015
3	Natalizumab (Tysabri)FDA Link 11/2015 - 03/2013
2	upadacitinibIBA 06/2022 - 01/2020
2	ozanimodIBA 04/2022 - 01/2022
2	Janus Kinase 1IBA 11/2021 - 09/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2021 - 10/2020
2	Azathioprine (Imuran)FDA LinkGeneric 01/2021 - 01/2013
2	Vitamin D FDA LinkGeneric 01/2021 - 01/2016
2	SmokeIBA 10/2020 - 04/2012
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2018
2	Metronidazole (Metric)FDA LinkGeneric 09/2019 - 01/2005
2	Calcibiotic Root Canal SealerIBA 01/2019 - 05/2008
2	Angiotensin IIIBA 01/2019 - 01/2016
2	ReninIBA 01/2019 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 04/2015
2	3' Untranslated Regions (3' UTR)IBA 09/2017 - 01/2017
2	Certolizumab Pegol FDA Link 01/2016 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2012
2	Allopurinol (Remid)FDA LinkGeneric 02/2013 - 01/2012
2	2-mercaptopurineIBA 02/2013 - 01/2012
2	Rifaximin (L 105)FDA Link 01/2011 - 01/2005
1	Interleukin-12 (IL 12)IBA 05/2022

Therapy/Procedure

82	Therapeutics 11/2022 - 06/2005
17	Colectomy 01/2022 - 06/2005
15	Restorative Proctocolectomy 01/2022 - 06/2006
9	Fecal Microbiota Transplantation 01/2021 - 12/2012
8	Biological Therapy 02/2022 - 12/2012
4	Remission Induction 01/2022 - 11/2015
4	Ileostomy 01/2022 - 04/2016
4	Chemoprevention 01/2017 - 06/2005
3	Secondary Prevention 02/2022 - 09/2006
2	Colonic Pouches (S Pouch) 01/2022 - 01/2022
2	Drug Tapering 07/2021 - 01/2012
2	Radiotherapy 07/2009 - 08/2005